Sex-Specific Patterns of Multisystem Aging: Mechanisms, Clinical Impact, and Emerging Therapies

Abstract

Multisystem aging demonstrates marked sex-specific patterns, influencing disease susceptibility, progression, and outcomes across diverse organ systems. This review synthesizes contemporary evidence regarding the epidemiology, pathophysiology, risk factors, clinical features, diagnostic considerations, and management strategies for age-associated multisystem changes in men and women. Emphasis is placed on mechanistic underpinnings, clinical relevance, and recent advances, providing clinicians with a comprehensive framework to individualize care and anticipate distinctive aging trajectories by sex.

Introduction

Aging is a complex, multifactorial process involving progressive decline in physiological function across multiple organ systems. Sex-specific differences in aging have been increasingly recognized, with implications for disease prevalence, phenotypic presentation, and therapeutic response. Understanding these distinctions is crucial for optimizing preventive, diagnostic, and management strategies in geriatric medicine and for tailoring interventions according to patient sex. This article explores the scientific and clinical landscape of sex-specific multisystem aging, guided by recent research and guideline-based recommendations.

Epidemiology / Disease Burden

Global demographic shifts have increased the proportion of older adults, amplifying the clinical burden of age-related pathologies. Women generally experience greater longevity than men but with increased years spent in morbidity, particularly from chronic non-communicable diseases such as osteoporosis, dementia, and autoimmune disorders. Men, conversely, exhibit higher rates of cardiovascular events, metabolic syndrome, and certain cancers earlier in the aging process. These sex-specific burdens are further stratified by ethnicity, socioeconomic status, and access to healthcare, underscoring the need for nuanced epidemiological surveillance and targeted interventions.

Pathophysiology

Sex differences in multisystem aging are rooted in a complex interplay of hormonal, genetic, epigenetic, and environmental factors. Estrogen and testosterone exert divergent effects on cellular senescence, mitochondrial function, immune modulation, and DNA repair pathways. For instance, estrogen has neuroprotective, vasodilatory, and anti-inflammatory properties, partially explaining the later onset of cardiovascular disease in women. Conversely, accelerated telomere attrition and heightened oxidative stress are more pronounced in aging men. Sex chromosomes (XX vs. XY) modulate gene expression, compounding these differences. Additionally, men and women exhibit distinct gut microbiota profiles, which may further influence systemic inflammation and metabolic health during aging.

Risk Factors

Sex-specific risk factors for multisystem aging encompass intrinsic (biological) and extrinsic (environmental, lifestyle) contributors. In women, menopause and the associated decline in endogenous estrogens accelerate bone loss, dyslipidemia, and cognitive vulnerability. Pregnancy history, use of hormone replacement therapy, and autoimmune predisposition further modulate risk. In men, andropause is characterized by gradual testosterone decline, increasing susceptibility to sarcopenia, visceral adiposity, and insulin resistance. Behavioral risk factors including smoking, alcohol use, and occupational exposures exhibit sex-dependent prevalence and impact on aging-related outcomes.

Clinical Features

Clinical manifestations of multisystem aging exhibit significant sex-specificity. Women more frequently present with osteoporotic fractures, polymyalgia rheumatica, and Alzheimer’s disease, while men are predisposed to coronary artery disease, Parkinson’s disease, and certain malignancies (e.g., prostate, bladder). Sarcopenia, frailty, and functional decline demonstrate greater severity at younger ages in men but higher overall prevalence in older women due to longer survival. Importantly, symptom presentations may differ: women with myocardial infarction often report atypical symptoms, complicating timely diagnosis and management.

Diagnosis

Sex-specific diagnostic strategies are warranted to enhance early detection of age-related disorders. For example, bone mineral density screening thresholds and fracture risk calculators must be interpreted in a sex-specific context. Cardiovascular risk algorithms, cognitive screening tools, and frailty indices should incorporate sex as a variable to improve predictive accuracy. Biomarker profiles, including inflammatory cytokines and hormonal assays, demonstrate divergent trajectories in aging men and women, necessitating tailored reference ranges and interpretation frameworks.

Treatment & Management

Optimal management of age-associated conditions requires individualized, sex-specific approaches. Hormone replacement therapy in postmenopausal women remains controversial, with current guidelines emphasizing personalized risk–benefit assessment. Cardiovascular risk reduction in men may prioritize aggressive blood pressure and lipid management, while women benefit from osteoporosis screening and prevention strategies. Pharmacokinetic and pharmacodynamic differences influence drug metabolism and adverse event profiles by sex. Multidisciplinary geriatric care models should integrate routine assessment of sex-specific risks, comorbidities, and functional capacity.

Recent Advances / Emerging Therapies

Emerging research highlights the promise of senolytic agents, epigenetic modulators, and immunotherapies in mitigating multisystem aging, with preliminary data suggesting sex-dependent efficacy. Advances in genomics and proteomics facilitate deeper characterization of sex-specific molecular pathways, enabling the development of precision gerotherapeutics. Ongoing trials are evaluating the impact of selective estrogen and androgen receptor modulators on cardiovascular, musculoskeletal, and cognitive outcomes in older adults. Personalized lifestyle interventions, including sex-tailored exercise and nutrition programs, are gaining traction for their role in preserving multisystem health.

Guideline Recommendations

International guidelines increasingly acknowledge sex differences in aging, recommending sex-specific screening intervals, diagnostic thresholds, and preventive interventions. The American College of Cardiology, National Osteoporosis Foundation, and International Association of Gerontology and Geriatrics advocate for incorporation of sex as a critical determinant in clinical decision-making for older adults. Ongoing updates to geriatric assessment protocols emphasize the integration of sex-specific risk stratification tools and multidisciplinary management pathways.

Conclusion

Sex-specific patterns of multisystem aging reflect nuanced biological, clinical, and societal determinants, demanding precision approaches in geriatric care. Recent advances in mechanistic understanding and therapeutic innovation hold promise for individualized prevention and management of age-associated diseases. Clinicians should remain vigilant to the unique trajectories and needs of aging men and women, incorporating evidence-based, sex-sensitive strategies to optimize healthspan and quality of life in the growing older population.